influenza vaccines 結果共3筆

Taiwan’s Centers for Disease Control (CDC) warns of a potential flu epidemic around the Lunar New Year due to an increase in Type B influenza infections. Over 6 million government-funded flu vaccines have been administered, with a vaccination rate exceeding 50% among senior citizens. Several counties have reached the target vaccination rate of 55% for seniors. Influenza outpatient and emergency department visits have shown a recent downward trend, but adenoviruses remain the leading respiratory pathogens. H3N2 is more prevalent than H1N1, with a rising proportion of Type B influenza cases. There have been 14 new severe influenza complications and three additional deaths, mainly affecting individuals with chronic illnesses who were unvaccinated. As of December 11, 6.098 million public-funded flu vaccine doses have been administered, achieving a vaccination rate of 50.4%. Officials urge eligible citizens to promptly get vaccinated, as approximately 500,000 doses of government-funded flu vaccine remain.

The Taiwan FactCheck Center has clarified that MVC’s quadrivalent influenza vaccine is produced by the reputable South Korean pharmaceutical firm GC Biopharma, which has WHO qualification and is marketed in multiple countries. Additionally, the FactCheck Center noted that MVC’s method of vaccine production is not unprecedented, as other domestic manufacturers have also imported foreign vaccine stock solutions for local assembly.

Taiwan prioritizes 65+ for Moderna vaccine, offers test kits and vouchers. Hospitals see a 30% increase in patients. Doctors urge prompt antiviral medication for flu. Elderly advised to get COVID and flu vaccines, with pneumococcal vaccine later.